SS Innovations International, Inc. 8K

SS Innovations International, Inc. announced strong first quarter 2026 financial results with record revenue, improved margins, and a capital-raising private placement alongside continued global regulatory and installation growth for its SSi Mantra surgical robotic system.

SS Innovations International, Inc. reported unaudited financial results for the quarter ended March 31, 2026, highlighting record quarterly revenue of $11.1 million (up 116.8% year-over-year) driven primarily by increased SSi Mantra surgical robotic system and instrument sales, a significant improvement in gross margin to 48.0%, and a reduced net loss of $3.6 million. The company also disclosed that it completed a March 9, 2026 private placement of common stock yielding approximately $18.6 million in gross proceeds, ended the quarter with $16.0 million in cash and cash equivalents and no long-term debt, and continued to expand its installed base and procedure volume, including new regulatory approvals for SSi Mantra in Sri Lanka and Kenya and telesurgery approvals in Indonesia and the Philippines, while progressing toward anticipated U.S. FDA 510(k) clearance and EU CE marking in 2026.

Filing Facts

CIK

1676163

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-055468

Alert Tier

7